|
Pursuing Innovation
The pursuit of innovation is basic to Pfizer's culture. It shapes our strategy, defines our purpose, and governs every facet of our operations - from research and development (R&D) that leads to pharmaceutical inventions, to the transfer of knowledge to patients and providers, to the way we respond to the changing marketplace.
Our medicines library includes about 3 million compounds. Our pipeline holds approximately 169 new molecular entities and 73 enhancement programs for marketed products in development and about 400 compounds in discovery research across multiple therapeutic areas.
Pfizer scientists have produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections. And today we're taking on some of the world's most difficult diseases, including cancer, arthritis, and osteoporosis.
Pfizer in India
- Pfizer Limited (India) has a turnover of US$ 172 million (November 2006)
- It is one of the fastest growing pharmaceutical companies in India with a consistent ‘higher than market’ growth rate in 2006
- Globally one of the highest spenders in pharmaceutical R&D, Pfizer has made clinical research investments of US $ 15.75 million in India
- The company was awarded the FICCI–SEDF (Socio Economic Development Foundation) Certificate of Commendation for its social responsibility efforts
- A 2006 survey has ranked Pfizer as the most respected MNC pharmaceutical company
About our products
- 5 products launched since 2005 - Vfend, Viagra, Lyrica, Caduet and Macugen
- 7 Pfizer brands feature among the Top-100 pharmaceutical brands in India
- 2 of Pfizer India's brands, Corex (cough formulation) and Becosules (multivitamin), continue to rank as the No.1 & 2 brands amongst all pharmaceutical drugs produced in India
- Pfizer has won the Golden Peacock Innovative Product for Magnex (Sulperazon) and Exubera (inhaled insulin)
Going beyond medicines
- In India, Pfizer instituted the first ever Disease Management Program - Healthy HeartTM in Cardio Vascular Disease (hypertension, chronic stable angina and dyslipidemia), in partnership with Apollo Hospital, Hyderabad and more recently with Apollo Hospital, Chennai
- Partner with Physician Associations to develop recommendations/ guidelines of managing specific diseases
- Provide medical information to physicians on drugs as well as therapeutic areas that we operate in
- A Pharmaco-Vigilance system wherein we track adverse events reported by physicians
Location & People
- Headquartered in Mumbai
- Over 2000 colleagues
- State-of-the-art manufacturing facility at Thane, Maharashtra
Academic Contribution
- Formed the Academy of Clinical Excellence (ACE) in collaboration with Bombay College of Pharmacy to provide professional training to investigators and other clinical research personnel
- Pfizer has also partnered with other pharmaceutical companies, contract research organizations and investigators to establish Indian Society for Clinical Research (ISCR) – a professional society aimed at raising the standards of clinical research
- Pfizer Education And Research League (PEARL) is a new initiative in which Pfizer seeks to partner with institutes to improve existing clinical research and continuing medical educational capabilities.
|
